scorecardresearch
Saturday, April 27, 2024
TopicSerum Institute India

Topic: Serum Institute India

DCGI directs Serum Institute of India to suspend recruitment for Oxford vaccine trials

DCGI's Dr V G Somani Friday also directed SII to increase the safety monitoring of the subjects already vaccinated as part of the trial, and submit the plan and report.

India halts clinical trial of Oxford-AstraZeneca Covid vaccine

Serum Institute received a show-cause notice from India's drug regulator after AstraZeneca announced it had paused trials in UK amid safety concerns.

Drug regulator sends notice to Serum Institute over AstraZeneca vaccine trial

DCGI issued a show-cause notice to Serum Institute following reports that human trials of the Oxford vaccine were paused in UK after a candidate had an adverse reaction.

Oxford’s new Covid vaccine begins human trials in partnership with Serum Institute of India

Serum Institute of India, the world’s largest vaccine manufacturer, will run trials of the shot developed by SpyBiotech that uses a patented superglue tech to induce an immune response.

India holds the key for global access to Covid-19 vaccine

India has the potential to play a key role in overcoming vaccine nationalism because it is the major supplier of medicines to the global south.

Oxford Covid vaccine given to 2 volunteers as Serum Institute begins human trials in India

The Phase 2 trials began in Pune's Bharati Vidyapeeth Medical College and Hospital. A total of 25 volunteers will be enrolled at the hospital.

Govt got no requests for phase 3 trials of Russia’s Covid vaccine Sputnik V in India

Modi govt is looking at accessing data on the safety and efficacy of the Sputnik V vaccine through alternate channels.

After Oxford Covid vaccine dosing, trial participants to be given paracetamol ‘on SOS basis’

According to studies, the prophylactic use of paracetmol can allay concerns of high fever and other febrile reactions.

Pune’s Serum Institute set to start human trials of Oxford Covid vaccine, gets regulator nod

DCGI decision to allow human trials on 1,600 participants in India is based on data submitted by SII on first two phases of Oxford University trials.

SII proposes 1,600 subjects in 20 Indian cities for Oxford vaccine trials, govt to decide today

India’s apex clinical trial regulation body will meet urgently to reconsider Serum Institute of India’s proposal after it revised its plan for starting Oxford vaccine's human trials in India.

On Camera

Indira, Manmohan, Modi, all raised income inequality. Until Hindu fears took the driving seat

The issue of inequality has assumed the blazing limelight at a time when inequality in India is said to be higher than it was in the British Raj. It's a ripe situation for half-truths and incendiary statements.

Foreign policy resonating among more Indians in 2nd & 3rd tier towns of India, says EAM Jaishankar

Speaking at launch of economist Surjit Bhalla’s book, S Jaishankar also highlights Gen Z’s engagement with ‘reel culture’, which has 'promoted awareness, created interest in many subjects'.

Germany removes restrictions, India can now buy small arms from its firms

Germany’s erstwhile Christian Democratic Union govt, led by Angela Merkel, prevented sale of small arms to police forces in states they perceived had ‘bad human rights record’.

These 6 states are key for Modi’s ‘400 paar’ target. They’re also where Opposition can stop him

While this contest looks so predictable in large swathes of our political landscape, it is also more keenly contested than 2019 in some states.